These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 3896092

  • 1. [Effects of amrinone administered orally and by injection in heart failure].
    Bounhoure JP, Massabuau P, Puel J, Miquel JP, Calazel J.
    Ann Med Interne (Paris); 1985; 136(3):251-5. PubMed ID: 3896092
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Amrinone in acute and long-term therapy].
    Klepzig M, Kleinhans E, Büll U, Strauer BE.
    Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
    Robinson PJ, Lvoff R, Chong B, Barrett PA.
    Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
    Evans JR, Pacht K, Huss P, Unverferth DV, Bashore TM, Leier CV.
    Int J Clin Pharmacol Res; 1984 Dec; 4(1):9-18. PubMed ID: 6381344
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical experience with amrinone in patients with advanced congestive heart failure.
    Kinney EL, Carlin B, Ballard JO, Burks JM, Hallahan WF, Zelis R.
    J Clin Pharmacol; 1982 Oct; 22(10):433-40. PubMed ID: 7174853
    [Abstract] [Full Text] [Related]

  • 10. [Hemodynamic effects of various doses of a new inotropic: amrinoma].
    Cárdenas M, Vidaurri A.
    Arch Inst Cardiol Mex; 1979 Oct; 49(5):961-8. PubMed ID: 122781
    [Abstract] [Full Text] [Related]

  • 11. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ, Weber KT, Andrews V, Janicki JS.
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract] [Full Text] [Related]

  • 12. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Hashimoto K, Yabuuchi Y, Yamashita S, Mori T.
    Arzneimittelforschung; 1984 Aug; 34(3A):390-3. PubMed ID: 6540094
    [Abstract] [Full Text] [Related]

  • 13. Intravenous use of amrinone for the treatment of the failing heart.
    Mancini D, LeJemtel T, Sonnenblick E.
    Am J Cardiol; 1985 Jul 22; 56(3):8B-15B. PubMed ID: 2411122
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Side effects of amrinone therapy.
    Wilsmhurst PT, Webb-Peploe MM.
    Br Heart J; 1983 May 22; 49(5):447-51. PubMed ID: 6838732
    [Abstract] [Full Text] [Related]

  • 17. Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.
    Wilmshurst PT, Thompson DS, Juul SM, Dittrich HC, Dawson JR, Walker JM, Jenkins BS, Coltart DJ, Webb-Peploe MM.
    Br Heart J; 1985 May 22; 53(5):493-506. PubMed ID: 3994862
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
    Bottorff MB, Rutledge DR, Pieper JA.
    Pharmacotherapy; 1985 May 22; 5(5):227-37. PubMed ID: 3906583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.